Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data

Overview of attention for article published in Frontiers in Pharmacology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 925 followers.

New article: Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data https://t.co/cGVaujKHkZ #MDS #mdssm #hematology https://t.co/ubEe

29 Aug 2022

Reply Repost Favourite

New article: Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data https://t.co/C8mQWGacW5 #AML #leusm #hematology https://t.co/t5Qn

29 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.